CFO Resigns, page-24

OSA 42x will be the correctly weighted good news

Acetazolamide is already used to treat COPD patients as a respiratory stimulant to remove the need for mechanical ventilation in those patients...

it is also the FDA gold standard for the treatment of AMS ( acute mountain sickness)

and dronabinol has its runs on the board with the fda also
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806568/

both already approved - risk/benefit met and most effective in combined low dosage
- will indeed be good news